Telomir Pharmaceuticals, Inc. (TELO)
$1.16-$0.03 (-2.52%) Today
Erez Aminov - OfficerErez Aminov - OfficerErez Aminov - OfficerErez Aminov - OfficerTelomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. The company's research targets fundamental cellular processes associated with disease progression and functional decline, including metal-ion dysregulation, oxidative stress, epigenetic regulation, mitochondrial dysfunction, and telomere integrity. Telomir's investigational compound, Telomir-1 (Zn-Telomir), is a novel orally administered small molecule engineered to modulate intracellular metal balance particularly iron, copper, calcium, and zinc.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 3 | 150,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
9 Form 4 filings on record, the earliest from Nov 25, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Matthew Pratt Whalen - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 50,000 | $0.00 | - | |
| Edward Clouston Macpherson - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 50,000 | $0.00 | - | |
| Giudice Matthew Paul del - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 50,000 | $0.00 | - | |
| Erez Aminov - Officer | Grant or award | Incentive Stock Options (right to buy) | 1,960,170 | - | - | |
| Erez Aminov - Officer | Derivative | Incentive Stock Options (right to buy) | 1,960,170 | - | - | |
| Erez Aminov - Officer | Grant or award | Non-Qualified Stock Options (right to buy) | 2,000,000 | - | - | |
| Erez Aminov - Officer | Derivative | Non-Qualified Stock Options (right to buy) | 2,000,000 | - | - | |
| Matthew Pratt Whalen - Director | Grant or award | Incentive Stock Options (right to buy) | 25,000 | - | - | |
| Matthew Pratt Whalen - Director | Derivative | Incentive Stock Options (right to buy) | 25,000 | - | - | |
| Edward Clouston Macpherson - Director | Grant or award | Incentive Stock Options (right to buy) | 25,000 | - | - | |
| Edward Clouston Macpherson - Director | Derivative | Incentive Stock Options (right to buy) | 25,000 | - | - | |
| Giudice Matthew Paul del - Director | Grant or award | Incentive Stock Options (right to buy) | 25,000 | - | - | |
| Giudice Matthew Paul del - Director | Derivative | Incentive Stock Options (right to buy) | 25,000 | - | - | |
| Erez Aminov - Officer | Other | Common Stock | 7,319,710 | $1.37 | $10.03M | |
| Bay Shore Trust - 10% Owner | Gift | Common Stock (right to buy) | 100,000 | - | - |
Telomir Pharmaceuticals, Inc. (TELO) had 3 insider filings in the last 90 days, with the most recent on 2026-07-27. The full record for TELO runs to 9 Form 4 filings, the earliest from 2024-11-25. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of TELO were filed in the last 90 days.
No insider sales of TELO were filed in the last 90 days.
This page tracks TELO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add TELO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
$TENTSAKOS ENERGY NAVIGATION LTD
$TEOTELECOM ARGENTINA SA
$TGLTREASURE GLOBAL INC
$TGOPF3i GROUP PLC
$TGSGAS TRANSPORTER OF THE SOUTH INC
$THCPThunder Bridge Capital Partners IV, Inc.
$THEOBOA Acquisition Corp. II
$THQabrdn Healthcare Opportunities Fund
$THWabrdn World Healthcare Fund
$TIGOMILLICOM INTERNATIONAL CELLULAR SAEvery Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.